FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Erik Nygren

Research Profile

Chemicals & Drugs

Living Beings

Physiology

Immunity, Mucosal

Disorders

Anatomy

Co-author Network

Publications

TOP 3
Jan Holmgren; Anna Lundgren; Erik Nygren; L Bourgeois; N Carlin; J Clements; B Gustafsson; J Tobias; R Walker; Ann-Mari Svennerholm
Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
Michael Lebens; Erik Nygren; Margareta Blomquist; Agneta Ekman; Susanne Källgård; Stefan L Karlsson; Jan Holmgren
Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
Joshua Tobias; Jan Holmgren; Maria Hellman; Erik Nygren; Michael Lebens; Ann-Mari Svennerholm
Over-expression of major colonization factors of enterotoxigenic Escherichia coli, alone or together, on non-toxigenic E. coli bacteria.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Erik Nygren (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jan Holmgren; Anna Lundgren; Erik Nygren; L Bourgeois; N Carlin; J Clements; B Gustafsson; J Tobias; R Walker; Ann-Mari Svennerholm
Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
Vaccine 2013;31(20):2457-64.
2011: Michael Lebens; Erik Nygren; Margareta Blomquist; Agneta Ekman; Susanne Källgård; Stefan L Karlsson; Jan Holmgren
Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
Vaccine 2011;29(43):7505-13.
2010: Joshua Tobias; Jan Holmgren; Maria Hellman; Erik Nygren; Michael Lebens; Ann-Mari Svennerholm
Over-expression of major colonization factors of enterotoxigenic Escherichia coli, alone or together, on non-toxigenic E. coli bacteria.
Vaccine 2010;28(43):6977-84.
2009: Erik Nygren; Bin-Ling Li; Jan Holmgren; Stephen R Attridge
Establishment of an adult mouse model for direct evaluation of the efficacy of vaccines against Vibrio cholerae.
Infection and immunity 2009;77(8):3475-84.
2008: Erik Nygren; Jan Holmgren; Stephen R Attridge
Murine antibody responses following systemic or mucosal immunization with viable or inactivated Vibrio cholerae.
Vaccine 2008;26(52):6784-90.
2008: Annie George Chandy; Inger Nordström; Erik Nygren; Ing-Marie Jonsson; Jorge Postigo; L Vincent Collins; Kristina Eriksson
Th17 development and autoimmune arthritis in the absence of reactive oxygen species.
European journal of immunology 2008;38(4):1118-26.
2007: Anna Karlsson; Erik Nygren; Jennie Karlsson; Inger Nordström; Claes Dahlgren; Kristina Eriksson
Ability of monocyte-derived dendritic cells to secrete oxygen radicals in response to formyl peptide receptor family agonists compared to that of myeloid and plasmacytoid dendritic cells.
Clinical and vaccine immunology : CVI 2007;14(3):328-30.
2005: Jan Holmgren; Jenni Adamsson; Fabienne Anjuère; John Clemens; Cecil Czerkinsky; Kristina Eriksson; Carl-Fredrik Flach; Annie George Chandy; Ali M Harandi; Michael Lebens; Thomas Lehner; Marianne Lindblad; Erik Nygren; Sukanya Raghavan; Joaquin Sanchez; Michael Stanford; Jia-Bin Sun; Ann-Mari Svennerholm; Sara Tengvall
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.
Immunology letters 2005;97(2):181-8.
2005: Lars Bellner; Fredrik B Thorén; Erik Nygren; Jan-Ake Liljeqvist; Anna Karlsson; Kristina Eriksson
A proinflammatory peptide from herpes simplex virus type 2 glycoprotein G affects neutrophil, monocyte, and NK cell functions.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(4):2235-41.